Enterosys will attend NutrEvent 2022 in Nantes

NutrEvent is the event dedicated to innovation in Food, Feed, Nutrition and Health.

This year, NutrEvent is back for its 8th edition in hybrid format.

Enterosys will be present with a validated, complete and innovative offer of in vitro and in vivo preclinical efficacy tests rooted in the gut and inter organs communication.

Research

Categorie

Archives

Enterosys welcomes its new business developer

Pauline Caseilles have joined the Enterosys team this month as Scientific Business Developer. Its aim is to publicize Enterosys' service offerings. Pauline obtained a Master’s degree in Health Biology and a Specialized Mastere in Marketing and Sales also in the field...

Antioxidant and anti-inflammatory properties of maternal milk

The high hydrostatic pressure processing of donor milk may better protect preterm infants from gut and liver pathologies compared to Holder pasteurization, which is currently used in most human milk banks. Preterm infants are highly susceptible to oxidative stress due...

Targeting our second brain using prebiotics

The discovery of intestinal actors, such as enterosynes, able to modulate the ENS-induced duodenal contraction is an innovative approach. Among all the intestinal factors, the understanding of the role of gut microbes in controlling glycaemia remains a major target....

Commercial H/F – Biotechnologie

What we will accomplish together Pursue your career with a pure player in preclinical testing and accompany us in our growth! We need your scientific knowledge and your commercial appetite to build the commercial division! We are waiting for you at a key moment of our...